Literature DB >> 619948

A comparison of some physiological and psychological effects of Motival (fluphenazine and nortriptyline) and diazepam in normal subjects.

H Ashton, J E Millman, R Telford, J W Thompson.   

Abstract

1 The effects in normal subjects of a single oral dose of Motival (one tablet, containing fluphenazine 0.5 mg and nortriptyline 10 mg) on the contingent negative variation (CNV), reaction time, heart rate, blood pressure and self-rating scales for alertness, anxiety, tension, detachment and depression were compared with those of diazepam (5 mg and 7.5 mg) and placebo or propranolol (60 mg). 2 After diazepam (5 mg: twelve subjects and 7.5 mg: seven subjects) there was a significant decrease in CNV magnitude while after Motival (twelve subjects) there was no significant alteration in CNV magnitude compared to placebo. 3 After diazepam (7.5 mg: seven subjects) there was also a fall in subjective ratings for alertness and tension; this fall was significantly greater than the changes after Motival which did not reduce subjective ratings for alterness or tension below "average" levels. Anxiety ratings did not differ significantly between the two drugs. Changes after propranolol were intermediate in all scales. 4 It is concluded that under these conditions diazepam caused central nervous system depression while Motival did not.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 619948      PMCID: PMC1429237          DOI: 10.1111/j.1365-2125.1978.tb01615.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Contingent negative variation amplitudes. Marihuana and alcohol.

Authors:  B S Kopell; J R Tinklenberg; L E Hollister
Journal:  Arch Gen Psychiatry       Date:  1972-12

2.  Pharmacological studies of fluphenazine and nortriptyline in combination in man.

Authors:  A M Glegg; P Turner
Journal:  J Pharm Pharmacol       Date:  1971-02       Impact factor: 3.765

3.  The effect of caffeine, nitrazepam and cigarette smoking on the contingent negative variation in man.

Authors:  H Ashton; J E Millman; R Telford; J W Thompson
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1974-07

4.  The effects of methamphetamine and secobarbital on the contingent negative variation amplitude.

Authors:  B S Kopell; W K Wittner; D T Lunde; L J Wolcott; J R Tinklenberg
Journal:  Psychopharmacologia       Date:  1974-01-09

5.  Amphetamine effects in man: paradoxical drowsiness and lowered electrical brain acitivity (CNV).

Authors:  J J Tecce; J O Cole
Journal:  Science       Date:  1974-08-02       Impact factor: 47.728

6.  Chlorpromazine effects on brain activity (contingent negative variation) and reaction time in normal women.

Authors:  J J Tecce; J O Cole; J Savignano-Bowman
Journal:  Psychopharmacologia       Date:  1975-09-17

7.  Response to propranolol and diazepam in somatic and psychic anxiety.

Authors:  P J Tyrer; M H Lader
Journal:  Br Med J       Date:  1974-04-06
  7 in total
  4 in total

1.  Biphasic dose-related responses of the CNV (contingent negative variation) to I.V. nicotine in man.

Authors:  H Ashton; V R Marsh; J E Millman; M D Rawlins; R Telford; J W Thompson
Journal:  Br J Clin Pharmacol       Date:  1980-12       Impact factor: 4.335

2.  Effects of terfenadine and diphenhydramine alone or in combination with diazepam or alcohol on psychomotor performance and subjective feelings.

Authors:  L Moser; K J Hüther; J Koch-Weser; P V Lundt
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

3.  Central effects of single oral doses of propranolol in man.

Authors:  S A Salem; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

4.  The seed and the soil: effect of dosage, personality and starting state on the response to delta 9 tetrahydrocannabinol in man.

Authors:  H Ashton; J Golding; V R Marsh; J E Millman; J W Thompson
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.